Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,076,251
-
Share change
-
-436,846
-
Total reported value
-
$274,668,626
-
Put/Call ratio
-
19%
-
Price per share
-
$89.43
-
Number of holders
-
105
-
Value change
-
-$39,519,155
-
Number of buys
-
33
-
Number of sells
-
61
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2016
As of 30 Jun 2016 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,076,251 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, SOCIETE GENERALE, SG Americas Securities, LLC, AMERIPRISE FINANCIAL INC, and J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD.
This table shows 105 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.